J9177 Injection enfort vedo-ejfv 0.25mg
J-Codes
Also known as: enfortumab vedotin, Padcev
Intravenous injection of enfortumab vedotin-ejfv, a monoclonal antibody-drug conjugate targeting nectin-4, dosed per 0.25 milligram.
Clinical Context
Used for advanced urothelial cancer expressing nectin-4, delivering microtubule-inhibiting toxin to tumor cells.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.